CME Group Inc.
DE ˙ XTRA ˙ US12572Q1058
217,80 € ↑3,15 (1,47%)
2026-06-03
AKTIENPREIS
SecurityDE:MX4A / CME Group Inc.
InstitutionNorthern Trust Corp
Latest Disclosed Ownership3,552,814 shares
Latest Disclosed Value $ 1,049,323,616
Northern Trust Corp reports 0.79% decrease in ownership of MX4A / CME Group Inc.

On May 14, 2026 - Northern Trust Corp filed a 13F-HR form disclosing ownership of 3,552,814 shares of CME Group Inc. (DE:MX4A) valued at $907,566,336 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 3,580,969 shares of CME Group Inc.. This represents a change in shares of -0.79% during the quarter. The current value of the position is $773,802,889 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F CME GROUP COM 12572Q105 3,552,814 -28,155 -0.79 1,049,324 7.30 0.0284
2026-02-17 2025-12-31 13F CME GROUP COM 12572Q105 3,580,969 -88,343 -2.41 977,891 -1.36 0.1247
2025-11-14 2025-09-30 13F CME GROUP COM 12572Q105 3,669,312 -122,137 -3.22 991,411 -5.13 0.1268
2025-08-13 2025-06-30 13F CME GROUP COM 12572Q105 3,791,449 -19,068 -0.50 1,044,999 3.37 0.1437
2025-05-13 2025-03-31 13F CME GROUP COM 12572Q105 3,810,517 -132,937 -3.37 1,010,892 10.38 0.1501
2025-02-14 2024-12-31 13F CME GROUP COM 12572Q105 3,943,454 403,920 11.41 915,788 17.26 0.1297
2024-11-13 2024-09-30 13F CME GROUP COM 12572Q105 3,539,534 -139,826 -3.80 780,998 7.97 0.1278
2024-08-14 2024-06-30 13F CME GROUP COM 12572Q105 3,679,360 -10,172 -0.28 723,362 -8.93 0.1219
2024-05-14 2024-03-31 13F CME GROUP COM 12572Q105 3,689,532 -89,735 -2.37 794,319 -0.20 0.1372
2024-02-13 2023-12-31 13F CME GROUP COM 12572Q105 3,779,267 111,129 3.03 795,914 8.37 0.1441
2023-11-13 2023-09-30 13F CME GROUP COM 12572Q105 3,668,138 172,264 4.93 734,435 13.38 0.1423
2023-08-11 2023-06-30 13F CME GROUP COM 12572Q105 3,495,874 -230,346 -6.18 647,750 -9.23 0.1245
2023-05-15 2023-03-31 13F CME GROUP COM 12572Q105 3,726,220 -3,355 -0.09 713,646 13.79 0.1415
2023-02-13 2022-12-31 13F CME GROUP COM 12572Q105 3,729,575 70,589 1.93 627,165 -3.23 0.1316
2022-11-14 2022-09-30 13F CME GROUP COM 12572Q105 3,658,986 -12,786 -0.35 648,117 -13.77 0.1480
2022-08-12 2022-06-30 13F CME GROUP COM 12572Q105 3,671,772 -32,545 -0.88 751,613 -14.70 0.1610
2022-05-13 2022-03-31 13F CME GROUP COM 12572Q105 3,704,317 -25,669 -0.69 881,109 3.40 0.1550
2022-02-08 2021-12-31 13F CME GROUP COM 12572Q105 3,729,986 -39,561 -1.05 852,152 16.90 0.1396
2021-11-15 2021-09-30 13F CME GROUP COM 12572Q105 3,769,547 -997 -0.03 728,955 -9.10 0.1290
2021-08-13 2021-06-30 13F CME GROUP COM 12572Q105 3,770,544 -129,083 -3.31 801,919 0.69 0.1413
2021-05-12 2021-03-31 13F CME GROUP COM 12572Q105 3,899,627 -33,664 -0.86 796,420 11.22 0.1481
2021-02-11 2020-12-31 13F CME GROUP COM 12572Q105 3,933,291 -153,735 -3.76 716,057 4.72 0.1395
2020-11-16 2020-09-30 13F CME GROUP COM 12572Q105 4,087,026 -9,564 -0.23 683,801 2.69 0.1499
2020-08-14 2020-06-30 13F CME GROUP COM 12572Q105 4,096,590 82,669 2.06 665,860 -4.06 0.1578
2020-05-14 2020-03-31 13F CME GROUP COM 12572Q105 4,013,921 -401 -0.01 694,047 -13.86 0.1993
2020-02-14 2019-12-31 13F CME GROUP COM 12572Q105 4,014,322 -111,571 -2.70 805,754 -7.59 0.1803
2019-11-13 2019-09-30 13F CME GROUP COM 12572Q105 4,125,893 -78,346 -1.86 871,967 6.85 0.2087
2019-08-13 2019-06-30 13F CME GROUP COM 12572Q105 4,204,239 -8,251 -0.20 816,085 17.71 0.1936
2019-05-13 2019-03-31 13F CME GROUP COM CL A 12572Q105 4,212,490 42,753 1.03 693,291 -11.62 0.1712
2019-02-12 2018-12-31 13F CME GROUP COM CL A 12572Q105 4,169,737 293,957 7.58 784,411 18.90 0.2200
2018-11-14 2018-09-30 13F CME GROUP COM CL A 12572Q105 3,875,780 -14,478 -0.37 659,697 3.45 0.1615
2018-09-18 2018-06-30 13F/A-1 CME GROUP COM CL A 12572Q105 3,890,258 -22,242 -0.57 637,691 0.77 0.1619
2018-08-14 2018-06-30 13F CME GROUP COM CL A 12572Q105 3,912,435 -65 641,326
2018-05-09 2018-03-31 13F CME GROUP COM CL A 12572Q105 3,912,500 -28,119 -0.71 632,808 9.95 0.1646
2018-02-14 2017-12-31 13F CME GROUP COM CL A 12572Q105 3,940,619 -7,013 -0.18 575,527 7.45 0.1458
2017-11-13 2017-09-30 13F CME GROUP COM CL A 12572Q105 3,947,632 218,575 5.86 535,614 14.69 0.1396
2017-08-11 2017-06-30 13F CME GROUP COM 12572Q105 3,729,057 -86,272 -2.26 467,028 3.04 0.1306
2017-05-12 2017-03-31 13F CME GROUP COM 12572Q105 3,815,329 58,169 1.55 453,262 4.59 0.1307
2017-02-13 2016-12-31 13F CME GROUP COM 12572Q105 3,757,160 35,147 0.94 433,389 11.40 0.1329
2016-11-09 2016-09-30 13F CME GROUP COM 12572Q105 3,722,013 37,203 1.01 389,026 8.39 0.1212
2016-08-12 2016-06-30 13F CME GROUP COM 12572Q105 3,684,810 59,391 1.64 358,901 3.16 0.1165
2016-08-19 2016-03-31 13F/A-1 CME GROUP COM 12572Q105 3,625,419 14,364 0.40 347,905 6.34 0.1154
2016-05-13 2016-03-31 13F Cme Group COMM 12572Q105 3,625,400 348,220
2016-02-12 2015-12-31 13F Cme Group COMM 12572Q105 3,611,055 -268,892 -6.93 327,161 -9.08 0.1084
2015-11-12 2015-09-30 13F Cme Group COMM 12572Q105 3,879,947 131,568 3.51 359,826 3.15 0.1201
2015-08-13 2015-06-30 13F CME GROUP COM 12572Q105 3,748,379 -98,858 -2.57 348,825 -4.27 0.2365
2015-08-13 2015-06-30 13F Cme Group COMM 012572Q10 83,285 -3,763,952 7,751 0.0053
2015-05-14 2015-03-31 13F Cme Group COMM 12572Q105 3,847,237 -92,068 -2.34 364,372 4.34 0.1096
2015-02-12 2014-12-31 13F Cme Group COM 12572Q105 3,939,305 -27,369 -0.69 349,219 10.11 0.1054
2014-11-13 2014-09-30 13F Cme Group COMM 12572Q105 3,966,674 -153,715 -3.73 317,156 8.49 0.0996
2014-08-14 2014-06-30 13F CME GROUP com 12572Q105 4,120,389 -13,823 -0.33 292,341 -4.47 0.0911
2014-05-14 2014-03-31 13F CME GROUP COMM 12572Q105 4,134,212 -70,720 -1.68 306,015 -7.25 0.0963
2014-02-21 2013-12-31 13F/A-1 CME GROUP COM 12572Q105 4,204,932 101,380 2.47 329,918 8.82 0.1058
2014-02-12 2013-12-31 13F CME GROUP COM 12572Q105 4,204,932 329,918
2013-11-13 2013-09-30 13F CME GROUP COM 12572Q105 4,103,552 -487,122 -10.61 303,171 -13.05 0.1068
2013-08-09 2013-06-30 13F CME GROUP COM 12572Q105 4,590,674 4,590,674 348,662 0.1264
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.